Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Fischer Medical VenturesBOM:524743 -0.42%45 Gross Margin % is 27.32% as of Mar. 2026, which is 27% above its 10-year median of 21.58. GuruFocus rates BOM:524743 with a GF Score™ of 45/100 and a GF Value™ of ₹219.09 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 807 Medical Devices & Instruments companies, Fischer Medical Ventures ranks worse than 72.86% on this metric.
BOM:524743's Gross Margin % is ranked worse than 72.86% of 807
companies
in the Medical Devices & Instruments industry
Industry Median: 52.03
vs BOM:524743: 36.62
Fischer Medical Ventures had a gross margin of 27.32% for the quarter that ended in Mar. 2026 => Competition eroding margins
Fischer Medical Ventures (BOM:524743) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Fischer Medical Ventures had a gross margin of 27.32% for the quarter that ended in Mar. 2026 => Competition eroding margins
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Fischer Medical Ventures Gross Margin % Related Terms
Fischer Medical Ventures Gross Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:524743 vs ABT, SYK, MDT: Gross Margin % Comparison
For the Medical Devices subindustry, Fischer Medical Ventures's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fischer Medical Ventures Gross Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Fischer Medical Ventures's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Fischer Medical Ventures's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Fischer Medical Ventures (BOM:524743) has a Gross Margin % of 27.32% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Fischer Medical Ventures and its competitors. This is 27% above median its historical median of 21.58. Over the past decade, Fischer Medical Ventures' Gross Margin % has ranged from 17.26 to 36.62. According to the industry distribution chart, Fischer Medical Ventures ranks #588 out of 807 companies in the Medical Devices & Instruments industry, placing it in the top 72.9%.
Is Fischer Medical Ventures' Gross Margin % too high?
Fischer Medical Ventures' current Gross Margin % of 27.32% is 27% above median its 10-year median of 21.58. Over the past 10 years, this metric has ranged from a low of 17.26 to a high of 36.62. The Medical Devices & Instruments industry median Gross Margin % is 52.03. Fischer Medical Ventures' value of 27.32% is 47.5% below this industry median. Based on the distribution chart, Fischer Medical Ventures ranks #588 out of 807 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Fischer Medical Ventures has a GF Score™ of 45/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Fischer Medical Ventures' Gross Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Fischer Medical Ventures ranks #588 out of 807 companies for Gross Margin %. This places Fischer Medical Ventures in the lower half of its industry. The industry median Gross Margin % is 52.03. Fischer Medical Ventures' value of 27.32% is 47.5% below this benchmark. Historically, Fischer Medical Ventures' own Gross Margin % has ranged from 17.26 to 36.62 over the past decade. While the company's 10-year median is 21.58 vs. the industry median of 52.03, Fischer Medical Ventures has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Devices & Instruments company?
The median Gross Margin % among Medical Devices & Instruments companies is 52.03, based on 807 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Fischer Medical Ventures's current Gross Margin % of 27.32% is 47.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Fischer Medical Ventures and its competitors. For the Medical Devices & Instruments industry, the median Gross Margin % is 52.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fischer Medical Ventures's current Gross Margin % is 27.32%, which is 27% above median its own 10-year median of 21.58. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fischer Medical Ventures stock overvalued right now?
Based on GuruFocus' analysis, Fischer Medical Ventures (BOM:524743) is currently considered Possible Value Trap. The stock's GF Value™ is ₹219.09, compared to a current price of ₹38.06 — trading 82.6% below its estimated fair value. The current Gross Margin % is 27.32%, which is 27% above median its 10-year median of 21.58 and 47.5% below the Medical Devices & Instruments industry median of 52.03. Fischer Medical Ventures' overall GF Score™ is 45/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Fischer Medical Ventures (BOM:524743), the current Gross Margin % is 27.32% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Fischer Medical Ventures (BOM:524743) Overvalued in 2026?
Based on GuruFocus' analysis, Fischer Medical Ventures stock appears to be undervalued.
The current stock price of ₹38.06 is trading 82.6% below its estimated GF Value™ of ₹219.09.
GuruFocus considers Fischer Medical Ventures to be Possible Value Trap.
Key valuation signals for BOM:524743:
Gross Margin %: 27.32% (27% above median its 10-year median of 21.58)
GF Value™: ₹219.09 vs. price of ₹38.06 (82.6% below fair value)
Industry Position: 47.5% below the Medical Devices & Instruments median (#588 of 807)
No single metric tells the full story. See the BOM:524743 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Fischer Medical Ventures Ltd is engaged in developing and trading of Medical Equipment including cutting-edge Magnetic Resonance Imaging (MRI) systems in India.
45GF Score
Get the complete analysis for BOM:524743
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:524743 has been successfully added to your 
